Purchases and Sales Made in Q3 2022 in Akebia Therapeutics, Inc. (AKBA)
This table provides information about the institutional ownership of Akebia Therapeutics, Inc. (AKBA) during Q3 2022. The information is specifically focused on institutions that hold shares of Akebia Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-156K- 34.14% |
$46.8K - $71.8K
|
301K
$1.11M
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-183K- 39.43% |
$55K - $84.4K
|
282K
$1.04M
|
|
|
Nov 14, 2022
Q3 2022
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-189K- 9.5% |
$56.7K - $86.9K
|
1.8M
$6.64M
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-232K- 75.04% |
$69.7K - $107K
|
77.3K
$285K
|
|
|
Nov 14, 2022
Q3 2022
|
Bayesian Capital Management, LP
Brooklyn, NY |
SELL
|
- |
-236K- 77.44% |
$70.7K - $108K
|
68.6K
$253K
|
|
|
Nov 09, 2022
Q3 2022
|
Principal Financial Group Inc
Des Moines, IA |
SELL
|
- |
-250K- 60.42% |
$75.1K - $115K
|
164K
$605K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-309K- 47.07% |
$92.7K - $142K
|
348K
$1.28M
|
|
|
Nov 14, 2022
Q3 2022
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-389K- 64.95% |
$117K - $179K
|
210K
$774K
|
|
|
Nov 14, 2022
Q3 2022
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-684K- 80.54% |
$205K - $315K
|
165K
$610K
|
|
|
Nov 14, 2022
Q3 2022
|
Hrt Financial LP
New York, NY |
SELL
|
- |
-1.08M- 97.88% |
$324K - $497K
|
23.5K
$86.5K
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.87M- 34.99% |
$562K - $862K
|
3.48M
$12.8M
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-3.08M- 18.92% |
$923K - $1.42M
|
13.2M
$48.6M
|